2022 | NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan | Hwang, Wen-Li; Chen, Tsung-Chih; Lin, Hsuan-Yu; Chang, Ming-Chih; Hsiao, Pei-Ching; Bai, Li-Yuan; Kuo, Ching-Yuan; Chen, Yeu-Chin; Liu, Ta-Chih; Gau, Jyh-Pyng; Wang, Po-Nan; Hwang, Wei-Shou; Kuo, Ming-Chung; Liu, Chun-Yu; Liu, Yi-Chang; Ma, Ming-Chun; Su, Nai-Wen; Wang, Chuan-Cheng; Wu, Yi-Ying; MING YAO ; Yeh, Su-Peng; Cheng, Hao-Wei; Lee, Yee-Ming; Ku, Fan-Chen; JIH-LUH TANG | International journal of hematology | 2 | 2 | |
2015 | Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study | Chen, Li-Tzong; Jeng, Long-Bin; Hsiao, Chin-Fu; Wu, Cheng-Chung; Lee, Wei-Chen; Wang, Tsang-En; Lee, Po-Huang; Chen, Chao-Long; Chen, I-Su; Lee, King-Teh; Hsieh, Chung-Bao; Hwang, Wei-Shou; Yang, Mei-Due; Yang, Yang-Sen; Lin, Deng-Yn; Chen, Miin-Fu; Chen, Pei-Jer | J. Clin. Oncol. | | | |